ERBB2 and cancer: As a result, focus has been placed on the development of novel therapeutic approaches that rely either on the use of various drug cocktails and treatment regimens that target multiple receptors or compensatory and downstream crosstalk signaling pathways of HER2, or, more recently, on triggering immune system responses that attack the cancer cells2.